1Pcrou CM, Softie T, Eisen MB, et al. Molecular portraits of human breast turnouts[ J]. Nature ,2000,406 (6797) :747 - 752.
2Abd El-Rehim DM, Ball G, Finder SE, et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent eDNA expression analyses[ J]. Int J Cancer, 2005,116(3) :340 -350.
3van Laer SJ,van den Eynden GG,Van der Auwera I,et al. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling [ J ]. Breast Cancer Res Treat, 2006,95(3) :243 -255.
4Weigeh B, Hu Z, He X, et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer[J].Cancer Res,2005,65(20) :9155 -9158.
5Softie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J]. Proc Natl Acad Sci USA,2001,98(19) :10869 - 10874.
6Nguyen PL,Taghian AG,Katz MS,et al. Breast cancer subtype approximated by estrogen receptor,progesterone receptor,and HER-2 is associated with local and distant recurrence after breast-conserving therapy [ J ]. J Clin Oncol,2008,26 ( 14 ) :2373 - 2378.
7Durbecq V,Ameye L, Veys l,et al. A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristics[J]. Crit Rev Oncol Hematol,2008,67 (1) :80 -92.
8Guarneti V, Broglio K, Kau SW, et al. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors [ J ]. J Clin Oncol, 2006,24 ( 7 ) : 1037 - 1044.
9Carey LA ,Perou CM ,Livasy CA ,et al. Race,breast cancer subtypes, and survival in the Carolina Breast Cancer Study[ J]. J Am Med Assoc,2006,295(21 ) :2492 -2502.
10Kurebayashi J, Moriya T, lshida T. The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races[ J]. Breast,2007,16 ( suppl 2 ) :72 - 77.
4Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [ J ]. JAMA,2006,295:2492 - 2502.
5NCI. Director's challenge: toward a molecular classifica- tion of tumors, http: //grauts. nih. gov/grauts/guide/ rfa files/RFA2CA2982027, html.
6Perou CM, Sorlie T, Eisen MB, et al. Molecular por-traits of human breast tumors [ J ]. Nature, 2000,406 : 747 - 752.
7Nguyen PL, Taghian AG, Katz MS, et al. Breast cancer subtype approximated by estrogen receptor, progesterone and HER- 2 is associated with local anddistant recur- rence after breast - conserving therapy [ J ]. J Clin On- col ,2008,26 (14) :2373 - 2379.
8Yu K, Lee CH, Tan PH, et al. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic population [J]. Clin Ca Res,2004,10(16) :5508 -5517.
9Delcasar JM, Martin A, Gareia C, et al. Characterization of breast cancer subtypes by quantitative assessment of biological parameters:Relationship with clinicopatholog- ical characteristics, biological features and prognosis [J]. Eur J Obstet Gynecol Reprod Biol,2008, 141: 147 - 152.
10Durbecq V, Ameye L, Veys I, et al. A significant pro- portion of elderly patients develop hormone - dependant "luminal B" tumours associated with aggressive charac- teristics [ J ]. Crit Rev Oncol Hematol, 2008,67 ( 1 ) : 80 - 92.
